UK-114502

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameUK-114502
Drug Alias NameUK-114502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsAngina PectorisSexual Dysfunction, Physiological
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Ltd
Active IndicationsN/A
Inactive IndicationsAngina PectorisSexual Dysfunction, Physiological

Other Information

ATC CodeN/A
Related LinksN/A